Get started
Author

Casie Mayne

OpenAlex ID: A5000808673
Ustekinumab dose escalation improves clinical responses in refractory Crohn’s disease
2020 · Syedreza A. Haider, Abhijeet Yadav, et al. · Therapeutic Advances in Gastroenterology · 35
Dual Biologic Therapy Induces Remission in Refractory Crohn’s Disease With Vedolizumab and Ustekinumab
2024 · Syed Adeel Hassan, Courtney Perry, et al. · Crohn s & Colitis 360 · 8
PDF
Peripheral Blood Extracellular Vesicle Lipids as Biomarkers for Human Inflammatory Bowel Disease
2023 · Syed Adeel Hassan, Courtney Perry, et al. · Gastroenterology · 1
P085 Dose Escalation (q4) of Ustekinumab Should Be Considered for Crohn’s Disease Patients Who Fail Standard Dosing
2020 · Abhijeet Yadav, Reza Haider, et al. · Inflammatory Bowel Diseases · 1
925 Comparison of Dysfunctional Non-healing Ulceration in Ibd to Physiologic (normal) Ulcer Healing in Healthy Adults: Surprising Roles of Mitochondria-driven Wnt Signaling and Antioxidant Responses
2026 · Neeraj Kapur, Sarayu Bhogoju, et al. · Gastrointestinal Endoscopy
925 Comparison of Dysfunctional Non-healing Ulceration in Ibd to Physiologic (normal) Ulcer Healing in Healthy Adults: Surprising Roles of Mitochondria-driven Wnt Signaling and Antioxidant Responses
2026 · Neeraj Kapur, Sarayu Bhogoju, et al. · Gastroenterology
Peripheral Blood Extracellular Vesicle Lipids as Biomarkers for Human Inflammatory Bowel Disease
2023 · Syed Adeel Hassan, Courtney Perry, et al. · Inflammatory Bowel Diseases
PDF
S2435 Remission of Sprue-Associated Collagenous Colitis With Ustekinumab
2021 · Aaron Brenner, Patrick J. Carey, et al. · The American Journal of Gastroenterology
P085 Dose Escalation (q4) of Ustekinumab Should Be Considered for Crohn's Disease Patients Who Fail Standard Dosing
2020 · Abhijeet Yadav, Reza Haider, et al. · Gastroenterology
Works count: 9
Citation count: 45
H-index: 2
I10-index: 1
Year
Topic
Type